Eagle Asset Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-922,101
Closed -$49.3M 681
2016
Q1
$49.3M Sell
922,101
-48,610
-5% -$3.59M 0.34% 93
2015
Q4
$110M Sell
970,711
-201,769
-17% -$22.2M 0.73% 17
2015
Q3
$138M Sell
1,172,480
-353,978
-23% -$46.2M 0.94% 7
2015
Q2
$118M Sell
1,526,458
-49,492
-3% -$3.24M 0.66% 27
2015
Q1
$91.2M Sell
1,575,950
-752,227
-32% -$31.9M 0.52% 48
2014
Q4
$75.1M Buy
2,328,177
+354,829
+18% +$10.7M 0.43% 70
2014
Q3
$48.3M Buy
1,973,348
+568,731
+40% +$11.6M 0.28% 124
2014
Q2
$24.9M Buy
1,404,617
+175,665
+14% +$2.83M 0.14% 205
2014
Q1
$24.6M Buy
+1,228,952
New +$23.8M 0.14% 215

Other funds holding ANAC

Eagle Asset Management's ANAC Position: Q2 2016 in Review

Eagle Asset Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 922,101 shares — an estimated $49.3M sold.

Eagle Asset Management first reported a position in ANAC in Q1 2014 and held it in 9 quarters. The position peaked at $138M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Eagle Asset Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Eagle Asset Management sold 922,101 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $49.3M.
  • Eagle Asset Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 9 quarters.
  • Eagle Asset Management's ANACOR PHARMACEUTICALS INC COM position peaked at $138M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Eagle Asset Management's 13F filing for Q2 2016, filed 19 Jul 2016.